Name: Glaucoma Management: Understanding Risk Factors, Screening and Treatment Options
Start: 2024-04-27T00:00:00-05:00
End: 2024-04-27T23:59:59-05:00

M	T	W	T	F	S	S
1 event 1 1 event, 1 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease February 10, 2024 - February 10, 2025 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease February 10, 2024 Take Me to the Event Registration EVENT Summary Dates Saturday, February 10, 2024, 11:00 AM ET, 10:00 AM CT, and 9:00 AM MT Location Virtual Target Audience Neurologists, nurse practitioners, and physician assistants involved in Alzheimer’s disease patient care. Format Zoom Webinar Credits 1.50 / AMA PRA Category 1 Credit(s)TM Cost Free Program…	1 event 2 1 event, 2 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 3 1 event, 3 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 4 1 event, 4 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 5 1 event, 5 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 6 1 event, 6 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 7 1 event, 7 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
1 event 8 1 event, 8 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 9 1 event, 9 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 10 1 event, 10 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 11 1 event, 11 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 12 1 event, 12 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 13 1 event, 13 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 14 1 event, 14 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
1 event 15 1 event, 15 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 16 1 event, 16 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 17 1 event, 17 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 18 1 event, 18 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 19 1 event, 19 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 20 1 event, 20 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 21 1 event, 21 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
1 event 22 1 event, 22 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 23 1 event, 23 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 24 1 event, 24 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 25 1 event, 25 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 26 1 event, 26 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	2 events 27 2 events, 27 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease 2024-04-27 Glaucoma Management: Understanding Risk Factors, Screening and Treatment Options Glaucoma Management: Understanding Risk Factors, Screening and Treatment Options April 27, 2024 Glaucoma Management: Understanding Risk Factors, Screening and Treatment Options April 27, 2024 Take Me to the Event Registration EVENT Summary Dates Saturday, April 27, 2024, 10:00 AM ET/9:00 AM CT Location Virtual Target Audience Ophthalmologists, optometrists, retina specialists, and advanced practice providers (physician assistants and nurse practitioners) Format Zoom Webinar Credits 1.50 / AMA PRA Category 1 Credit(s)TM 1.50 / COPE CE Credits Cost Free…	1 event 28 1 event, 28 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
1 event 29 1 event, 29 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease	1 event 30 1 event, 30 2024-02-10 New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease